智通财经获悉，2月5日，工信部等八部门联合印发《中药（核心股）工业高质量发展实施方案(2026— 2030年)》，从全产业链视角为中药工业未来五年发展划定"路线图"。《方案》围绕原料供应、创新能 力、制造水平等维度设定量化目标：到2030年培育60个高标准中药原料生产基地、建设5个中药工业守 正创新中心、新培育10个中成药大品种，推动一批医疗机构中药制剂转化为中药创新药，制修订10项中 药工业数智技术相关行业标准，发布20个数智化转型升级典型案例，建设20个智能工厂、培育10个绿色 工厂。 相关概念股： 中国中药（核心股）(00570)：中国中药汇集传统中药精髓，传承了自明代以来开创的"梁仲弘腊丸 馆"、"冯了性"、"同济堂"、"源吉林"等祖铺老号，拥有"冯了性"、"安宁"、"同济堂"3个中华老字 号，"仙灵"、"同济堂"、"仙灵骨葆"、"天江药业"、"德众"5个驰名商标。 同仁堂国药(03613)：同仁堂集团有望新增一家A股上市公司。嘉事堂近日公告称，2月2日，公司股东与 中国北京同仁堂(集团)有限责任公司签署股份转让协议，约定将光大实业、光大健康持有的公司股份以 14.6亿元转让给同仁堂集团。本次交易完成 ...

展望2026年， 国内中药材市场有望在政策引导、需求升级与产业转型的三重驱动下迎来好转。国家药 监局出台的《中药生产监督管理专门规定》将于2026年3月1日起正式实施，与此前已落地的《中药注册 管理专门规定》《中药标准管理专门规定》形成"三位一体"的监管闭环，进一步推动行业规范化、高质 量发展。 结构性分化将成为2026年中药材市场的核心特征。一方面，野生中药材资源枯竭的问题日益凸显，家种 品种价值攀升，北柴胡、关防风等品种供需缺口持续扩大，价格有望稳步上涨；另一方面，在健康消费 升级的背景下，药食同源品种需求呈现刚性增长态势，枸杞、黄芪等品种应用场景不断拓展，将带动原 料需求增加。 2月5日，工信部等八部门联合印发《中药工业高质量发展实施方案(2026—2030年)》，从全产业链视角 为中药工业未来五年发展划定"路线图"。《方案》围绕原料供应、创新能力、制造水平等维度设定量化 目标：到2030年培育60个高标准中药原料生产基地、建设5个中药工业守正创新中心、新培育10个中成 药大品种，推动一批医疗机构中药制剂转化为中药创新药，制修订10项中药工业数智技术相关行业标 准，发布20个数智化转型升级典型案例，建设 ...

证券日报网讯 1月29日，江中药业（600750）在互动平台回答投资者提问时表示，公司已于2023年建立 财务共享中心。目前，公司财务共享中心已综合运用数字化、智能化技术，提升流程效率并强化风险防 控，为公司高质量发展提供坚实支撑。 ...

Core Viewpoint - The implementation of the new regulations on traditional Chinese medicine (TCM) product labeling aims to eliminate the "unclear" status in safety information, enhancing the quality and safety of TCM products in the market [1][2][13]. Regulatory Changes - The new regulations, effective from July 1, 2023, require TCM product holders to manage the entire lifecycle of their products and improve the safety information in their labeling, specifically regarding contraindications, adverse reactions, and precautions [1][2]. - By July 1, 2026, any TCM product with "unclear" safety information will not be eligible for re-registration, emphasizing the urgency for companies to update their product labels [1][2]. Industry Response - Many pharmaceutical companies have begun revising their product labels to comply with the new regulations. For instance, companies like Rongchang Pharmaceutical and Yiling Pharmaceutical have completed revisions for their core products, ensuring clear safety information [11][12]. - The industry is adapting by adjusting procurement strategies to focus on compliant products and gradually reducing the inventory of those with high re-registration risks [14]. Market Observations - Despite the new regulations, some commonly used TCM products still display "unclear" safety information, indicating a gap in compliance that needs to be addressed [7][8]. - Reports indicate that TCM accounts for 12% of adverse drug reaction reports, highlighting the need for clearer safety information to mitigate risks associated with TCM usage [7][13]. Future Outlook - The new regulations are expected to promote a shift in the TCM industry from quantity expansion to quality prioritization, ultimately benefiting public health by providing clearer safety guidelines [13][14]. - The elimination of "unclear" labels is anticipated to enhance consumer confidence in TCM products, reducing the risk of unreasonable medication use [14].

北京中医药大学卫生健康法学教授邓勇向21世纪经济报道记者表示,距2026年7月1日《中药注册管理专 门规定》第七十五条落地仅剩半年，中成药行业正迎来监管与市场的双重变革，行业洗牌与转型升级全 面加速。 中成药再次站上了风口浪尖。 曾经说明书上那些模棱两可的"尚不明确"，即将成为历史，而中成药行业也在加速"低质"出清，产业升 级持续。 邓勇向记者指出，当前政策倒计时已对行业产生显著影响。大量中成药批文存在安全信息标注缺失问 题，企业主动注销、转让低价值批文的现象增多，监管部门密集发布说明书修订公告，合规压力持续攀 升。补齐品种毒理、临床真实世界数据等合规成本高昂，叠加生产监管新规实施，行业合规成本大幅上 涨。 同时，渠道端采购与招标倾向合规品种，低质产品市场空间持续被挤压。 根据本报此前报道，2026年7月1日，根据国家药监局规定，届时说明书上【禁忌】【不良反应】等关键 安全信息若仍标注"尚不明确"，药品将面临退市。 中国工程院院士张伯礼也对此向《科技日报》进行了回应，从近5年国家药品不良反应/事件报告看，中 药占12%，化学类药物占81%，中药相对安全。该规定的出台，核心目的是补齐中成药说明书安全信息 短板， ...

视频丨陈泽锴 中成药再次站上了风口浪尖。 曾经说明书上那些模棱两可的"尚不明确"，即将成为历史，而中成药行业也在加速"低质"出清，产业升 级持续。 北京中医药大学卫生健康法学教授邓勇向21世纪经济报道记者表示，距2026年7月1日《中药注册管理专 门规定》第七十五条落地仅剩半年，中成药行业正迎来监管与市场的双重变革，行业洗牌与转型升级全 面加速。 邓勇向记者指出，当前政策倒计时已对行业产生显著影响。大量中成药批文存在安全信息标注缺失问 题，企业主动注销、转让低价值批文的现象增多，监管部门密集发布说明书修订公告，合规压力持续攀 升。补齐品种毒理、临床真实世界数据等合规成本高昂，叠加生产监管新规实施，行业合规成本大幅上 涨。 同时，渠道端采购与招标倾向合规品种，低质产品市场空间持续被挤压。 根据本报此前报道，2026年7月1日，根据国家药监局规定，届时说明书上【禁忌】【不良反应】等关键 安全信息若仍标注"尚不明确"，药品将面临退市。 中国工程院院士张伯礼也对此向《科技日报》进行了回应，从近5年国家药品不良反应/事件报告看，中 药占12%，化学类药物占81%，中药相对安全。该规定的出台，核心目的是补齐中成药说明书安 ...

记者丨唐唯珂 编辑丨季媛媛 视频 丨陈泽锴 中成药再次站上了风口浪尖。 曾经说明书上那些模棱两可的"尚不明确"，即将成为历史， 而中成药行业也在加速"低质"出 清，产业升级持续。 北京中医药大学卫生健康法学教授邓勇向21世纪经济报道记者表示，距2026年7月1日《中药 注册管理专门规定》第七十五条落地仅剩半年，中成药行业正迎来监管与市场的双重变革，行 业洗牌与转型升级全面加速。 张伯礼指出，此次中成药再注册大考，本质上是中医药产业从"数量扩张"向"质量优先"转型的 必然选择。 完成"低质"出清 据了解，我国中成药多数获批时间较早，受历史条件限制，许多药品说明书存在安全信息缺失 问题。中国中药协会监测数据显示，截至2025年年底，我国中成药有效批准文号约5.7万个， 涉及约9000个品种， 其中超过4万个批文在禁忌、不良反应或注意事项等项目上标注为"尚不 明确"。 "这将主要影响两类药品。"中国中医科学院中药研究所中药化学中心主任刘安也在接受媒体采 访时说， 一是临床价值不明确 、安全风险较高的品种； 二是缺乏现代研究数据支撑的传统制 剂。 针对公众关心的家中备用板蓝根、连花清瘟等常用中成药能否继续使用的疑问， ...

鲁味斋在线上搭建了水浒、民国等七大主题直播间，将"幸福文化"融入销售。"董事长直播间"单场观看量最高达80万人次。2025年直播GMV 突破8000万元，成功吸引了大量年轻粉丝。 在生产车间，传统与现代完美融合。第三代传承人坚守"24味五香大料、8小时老卤浸润"的古法，同时引入智能生产线。他们针对年轻人研发 的低盐、藤椒等创新口味的产品，推出后仅用3个月，就占了门店销量的三成。 ■老字号·新潮牌｜以文化赋能，让卤味老字号"潮味"出圈 始创于1927年的鲁味斋，是拥有近百年历史的中华老字号，主营业务为卤味制品研发、生产与销售。鲁味斋近年来创新打造"博物馆集群"， 将厚重历史与现代体验结合。 从一颗消食片，到营养包软糖，变化的不仅仅是产品形态和口感，更是一个老字号面向新发展阶段的姿态与答案。真正的传承，不是对过去 的简单复刻，而是用今天的科技与视角，让传统健康智慧在新的消费生活中重新活起来，为健康中国贡献一份来自老字号的新力量。 ■湖南溆浦：腊月八打糍粑 香甜飘进千万家 在湖南省怀化市溆浦县黄茅园镇横坡村，有腊月八打糍粑的习俗。一大早，在姜氏糍粑的农家小院里，灶火燃起，热气腾腾的糯米饭已经蒸 上，不时传出来富有节 ...

Core Viewpoint - The report highlights the mixed performance of the top holdings in the Huatai-PineBridge Low Volatility ETF (512890), with various banks and companies showing different price movements during the trading session [1][5]. Group 1: Top Holdings Performance - As of the midday session, Shanghai Bank decreased by 0.54%, while Nanjing Bank increased by 0.29%. Other notable movements include Ping An Bank down by 0.09%, and Minsheng Bank up by 0.27% [1][5]. - The top ten holdings include Shanghai Bank, Nanjing Bank, Ping An Bank, and others, with varying performance metrics [2][9]. Group 2: Fund Flow and Market Trends - The Huatai-PineBridge Low Volatility ETF has seen significant net inflows, with 1.03 billion yuan over the last five trading days, 2.33 billion yuan over the last twenty days, and 4.58 billion yuan over the last sixty days [2][9]. - The fund's total circulation size reached 28.313 billion yuan as of January 27, 2026 [2][9]. Group 3: Market Analysis and Predictions - According to GF Securities, passive funds have significantly reduced their holdings in the banking sector, leading to weaker performance, with a total reduction of approximately 72.5 billion yuan, accounting for about 2% of the free float market value [4][11]. - Analysts suggest that the banking sector has adjusted to some pessimistic expectations, and the valuation is expected to stabilize, with large banks and wealth management banks likely to outperform [4][11]. - China Galaxy Securities indicates that the dividend distribution from listed banks remains strong and is expected to attract long-term capital [6][11]. Group 4: ETF Performance Metrics - The Huatai-PineBridge Low Volatility ETF has achieved a return of 36.04% over the past three years, outperforming its benchmark [6][11]. - The ETF is positioned as a stable investment tool in a volatile market, with options for investors to participate through regular investment plans or through its associated funds [6][11].

Economic Data - In 2025, China's total retail sales of consumer goods are expected to exceed 50 trillion yuan for the first time, reaching 50.1 trillion yuan, with a growth rate of 3.7% and a contribution rate of consumption to economic growth at 52%, an increase of 5 percentage points [6] - The number of motor vehicles in China is projected to reach 469 million by 2025, with 356 million being cars, and the number of drivers expected to reach 559 million, including 525 million car drivers [17] Trade and Policy - The U.S. announced an increase in tariffs on certain goods from South Korea to 25% due to the lack of approval from the South Korean parliament on a prior trade agreement [4] - The U.S. threatened to impose a 100% tariff on goods imported from Canada if Canada reaches a new trade agreement with China [5] - The Ministry of Commerce of China plans to expand market access and open up sectors such as telecommunications, healthcare, and education by 2026 [7] Financial and Investment - The People's Bank of China emphasized the need for proactive assessment of systemic financial risks and maintaining the stability of financial markets and the overall financial system [10] - The People's Bank of China will support the Hong Kong Monetary Authority in increasing the scale of RMB business funding arrangements from 100 billion yuan to 200 billion yuan [11] Corporate Developments - Shanghai-based AI startup StepFun completed over 5 billion yuan in Series B+ financing, setting a record for the largest single financing in the Chinese AI sector in the past 12 months [28] - Li Tong Electronics expects a net profit increase of 996.83% to 1240.57% in 2025, driven by profitability in its computing power business [35] - China Rare Earth anticipates a net profit of 143 million to 185 million yuan in 2025, marking a turnaround from a loss of 287 million yuan in the previous year [37] - Dongfang Risen expects a net loss of 2.3 billion to 2.9 billion yuan in 2025, despite a growing global photovoltaic installation market [54]